Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118233228> ?p ?o ?g. }
- W2118233228 endingPage "996" @default.
- W2118233228 startingPage "987" @default.
- W2118233228 abstract "The 773-residue ectodomain of the herpes simplex virus type 1 (HSV-1) glycoprotein B (gB) has been resistant to the use of mutagenic strategies because the majority of the induced mutations result in defective proteins. As an alternative strategy for the identification of functionally important regions and novel inhibitors of infection, we prepared a library of overlapping peptides homologous to the ectodomain of gB and screened for the ability of the peptides to block infection. Seven of 138 15-mer peptides inhibited infection by more than 50% at a concentration of 100 microM. Three peptides (gB94, gB122, and gB131) with 50% effective concentrations (EC(50)s) below 20 microM were selected for further studies. The gB131 peptide (residues 681 to 695 in HSV-1 gB [gB-1]) was a specific entry inhibitor (EC(50), approximately 12 microM). The gB122 peptide (residues 636 to 650 in gB-1) blocked viral entry (EC(50), approximately 18 microM), protected cells from infection (EC(50), approximately 72 microM), and inactivated virions in solution (EC(50), approximately 138 microM). We were unable to discern the step or steps inhibited by the gB94 peptide, which is homologous to residues 496 to 510 in gB-1. Substitution of a tyrosine in the gB122 peptide (Y640 in full-length gB-1) reduced the antiviral activity eightfold, suggesting that this residue is critical for inhibition. This peptide-based strategy could lead to the identification of functionally important regions of gB or other membrane proteins and identify novel inhibitors of HSV-1 entry." @default.
- W2118233228 created "2016-06-24" @default.
- W2118233228 creator A5010379792 @default.
- W2118233228 creator A5059226516 @default.
- W2118233228 creator A5077430669 @default.
- W2118233228 creator A5082646052 @default.
- W2118233228 creator A5088453479 @default.
- W2118233228 date "2009-03-01" @default.
- W2118233228 modified "2023-10-16" @default.
- W2118233228 title "Multiple Peptides Homologous to Herpes Simplex Virus Type 1 Glycoprotein B Inhibit Viral Infection" @default.
- W2118233228 cites W1488293738 @default.
- W2118233228 cites W1491815566 @default.
- W2118233228 cites W1498240938 @default.
- W2118233228 cites W1502427113 @default.
- W2118233228 cites W1523114181 @default.
- W2118233228 cites W1586368084 @default.
- W2118233228 cites W1602351046 @default.
- W2118233228 cites W1602748449 @default.
- W2118233228 cites W1634217411 @default.
- W2118233228 cites W1684170753 @default.
- W2118233228 cites W1747014860 @default.
- W2118233228 cites W1752010575 @default.
- W2118233228 cites W1793190047 @default.
- W2118233228 cites W1884766802 @default.
- W2118233228 cites W1912291173 @default.
- W2118233228 cites W1914319583 @default.
- W2118233228 cites W1919588248 @default.
- W2118233228 cites W1958561858 @default.
- W2118233228 cites W1964007399 @default.
- W2118233228 cites W1978771262 @default.
- W2118233228 cites W1981979611 @default.
- W2118233228 cites W1982655562 @default.
- W2118233228 cites W1984430631 @default.
- W2118233228 cites W1995497405 @default.
- W2118233228 cites W1996067969 @default.
- W2118233228 cites W1997221411 @default.
- W2118233228 cites W2000174737 @default.
- W2118233228 cites W2001694518 @default.
- W2118233228 cites W2005223868 @default.
- W2118233228 cites W2008486572 @default.
- W2118233228 cites W2014568747 @default.
- W2118233228 cites W2021148075 @default.
- W2118233228 cites W2024883244 @default.
- W2118233228 cites W2024965784 @default.
- W2118233228 cites W2027657241 @default.
- W2118233228 cites W2028027213 @default.
- W2118233228 cites W2029667189 @default.
- W2118233228 cites W2031698192 @default.
- W2118233228 cites W2036156017 @default.
- W2118233228 cites W2039006290 @default.
- W2118233228 cites W2042156810 @default.
- W2118233228 cites W2048948277 @default.
- W2118233228 cites W2050738479 @default.
- W2118233228 cites W2059855968 @default.
- W2118233228 cites W2069990125 @default.
- W2118233228 cites W2071171181 @default.
- W2118233228 cites W2075844985 @default.
- W2118233228 cites W2083083619 @default.
- W2118233228 cites W2085390874 @default.
- W2118233228 cites W2086769942 @default.
- W2118233228 cites W2099806165 @default.
- W2118233228 cites W2103738194 @default.
- W2118233228 cites W2112753652 @default.
- W2118233228 cites W2118016056 @default.
- W2118233228 cites W2127288704 @default.
- W2118233228 cites W2128725767 @default.
- W2118233228 cites W2133073089 @default.
- W2118233228 cites W2134005785 @default.
- W2118233228 cites W2137179268 @default.
- W2118233228 cites W2142520909 @default.
- W2118233228 cites W2143627435 @default.
- W2118233228 cites W2143783595 @default.
- W2118233228 cites W2151310245 @default.
- W2118233228 cites W2152680579 @default.
- W2118233228 cites W2153163492 @default.
- W2118233228 cites W2154733788 @default.
- W2118233228 cites W2156384617 @default.
- W2118233228 cites W2159293959 @default.
- W2118233228 cites W2159882498 @default.
- W2118233228 cites W2160152401 @default.
- W2118233228 cites W2163314722 @default.
- W2118233228 cites W2169263994 @default.
- W2118233228 cites W4229510242 @default.
- W2118233228 cites W4254750003 @default.
- W2118233228 doi "https://doi.org/10.1128/aac.00793-08" @default.
- W2118233228 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2650530" @default.
- W2118233228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19104014" @default.
- W2118233228 hasPublicationYear "2009" @default.
- W2118233228 type Work @default.
- W2118233228 sameAs 2118233228 @default.
- W2118233228 citedByCount "43" @default.
- W2118233228 countsByYear W21182332282012 @default.
- W2118233228 countsByYear W21182332282013 @default.
- W2118233228 countsByYear W21182332282014 @default.
- W2118233228 countsByYear W21182332282015 @default.
- W2118233228 countsByYear W21182332282016 @default.
- W2118233228 countsByYear W21182332282017 @default.
- W2118233228 countsByYear W21182332282018 @default.